Log In
Print
BCIQ
Print
Print this Print this
 

tabalumab (LY2127399)

Also known as: Anti-BAFF antibody

  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
DescriptionHuman IgG4 mAb targeting BLyS (BAFF)
Molecular Target BLyS (BAFF)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase II/III
Standard IndicationMultiple myeloma (MM)
Indication DetailsTreat previously treated multiple myeloma (MM)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today